BETHESDA, Md., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its 2012 Annual Shareholders Meeting will be held on Tuesday, August 14, 2012, at 9:00 a.m. at the Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, Maryland 20817.
